NCT04654442View on ClinicalTrials.gov

Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

May 5, 2021

Study Completion Date

May 5, 2021

Conditions
Covid19SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

TestNPass

Patients will undergo saliva sampling. Grenoble University Hospital lab will perform diagnosis using TestNPass IVDMD. Results won't be used for patient care (only recorded for RESEARCH purpose).

Trial Locations (1)

38043

Grenoble University Hospital, Grenoble

All Listed Sponsors
collaborator

Grapheal

UNKNOWN

lead

University Hospital, Grenoble

OTHER

NCT04654442 - Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample | Biotech Hunter | Biotech Hunter